Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

Trichoscopy helps diagnose hair and scalp problems but isn't always definitive and should be used with other methods.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Nanoparticles can be used to deliver drugs to hair follicles, potentially improving treatments for conditions like acne and alopecia, and could also be used for vaccine delivery and gene therapy.

Male pattern baldness is often genetic and linked to a hormone, with treatments like finasteride and minoxidil being effective for some men.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Fat tissue transplant may be an effective new treatment for severe, treatment-resistant hair loss from folliculitis decalvans.

Certain transcription factors are key in controlling skin stem cell behavior and could impact future treatments for skin repair and hair loss.

Ex vivo dermatoscopy may lower lab costs and improve diagnosis speed for hair loss biopsies.

Some immunosuppressed patients can get unusual skin infections from Malassezia, which can be treated with antifungal medication.

Scalp biopsy helps tell apart permanent and temporary hair loss types and guides treatment.

Fzd2 is important for skin and hair development through various signaling ways.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Azelaic acid may help treat acne by killing bacteria, reducing inflammation, and preventing clogged pores.

Older hair follicle stem cells have a reduced ability to renew themselves, leading to more hair loss.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Activating Nrf2 helps wounds heal faster by increasing hair follicle stem cells.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

Different races and genders have unique skin and hair issues, requiring specialized care and more research for effective treatment.

Cystic panfolliculoma is a rare, harmless tumor that can be confused with other skin tumors.

Localized dystrophic epidermolysis bullosa (DEB) can lead to scarring alopecia, highlighting the need to recognize and address this complication.

Trichofolliculoma was found in a person with amniotic band syndrome for the first time.

Early diagnosis of tufted hair is crucial for managing folliculitis decalvans, a chronic scalp condition.

The case shows how hard it is to tell apart Multiple Autoimmune Syndrome from other similar autoimmune conditions, but correct diagnosis is key for treatment to work.

A woman had a rare, non-cancerous skin growth on her face, which was removed and did not come back after a year.

A woman's rare benign eyelid tumor was correctly identified through detailed tissue analysis.

Trichofolliculoma, a rare benign hair follicle tumor, can potentially recur.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

Skin and hair renewal is maintained by both fast and slow cycling stem cells, with hair regrowth primarily driven by specific stem cells in the hair follicle bulge. These cells can also help heal wounds and potentially treat hair loss.